Purchase Order 75F40124P00472
Award Date
9/17/24
Potential Completion Date
9/19/25
Potential Value
$19K
Federal Agency
Food and Drug Administration
Awardee
Psomagen Inc.
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) awarded a $17,225 firm fixed price purchase order to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide whole genome sequencing for editing of pig genomes, which are approximately 2.7 gigabases in length. This contract was set aside for small business participation. Psomagen is a provider of advanced genomic and molecular biology services, including sequencing and data analysis, and has held multiple federal contracts and subcontracts supporting...
Psomagen Inc. has been awarded a firm fixed price purchase order from the Department of Health and Human Services Food and Drug Administration valued at $15,072.50 to provide whole genome sequencing and CVM Sanger services. The contract is set aside for total small businesses and will be completed by March 2023. Psomagen is a multiomics contract laboratory and data analysis provider that delivers genomic sequencing services to clinical, academic, and consumer markets. The company has...
This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
This federal contract, awarded by the National Institute on Aging (a civilian agency of the U.S. government), is for the purchase of whole genome sequencing services from the prime contractor, Psomagen Inc. The contract has a total ceiling value of $7,499,725.00 and is set aside for small businesses. Psomagen Inc. is a subsidiary of Macrogen, Inc. that specializes in providing a range of genomic sequencing, bioinformatics, and related services to federal agencies. Through this contract, Psomagen...
This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $4,250 firm fixed-price purchase order was for unspecified genomic and molecular biology services to support research initiatives at NHGRI. Psomagen Inc. has established itself as a key provider of advanced sequencing and omics capabilities to federal agencies, having been awarded numerous...
This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Psomagen Inc. for DNA and RNA sequencing of parental induced pluripotent stem cell (iPSC) lines. The contract has a ceiling value of $38,053.00 and a completion date of December 31, 2019. Psomagen Inc. is a wholly owned subsidiary of the larger company Macrogen, Inc. This award is an example of the sequencing and multi-omics services Psomagen provides to federal agencies...
This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...